Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Drinks per week

RABGAP1L · rs72715245

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−23, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 2,965,643 European ancestry, East Asian ancestry, Hispanic or Latin American, African ancestry individuals.

The effect Each copy of the T allele shifted the measure 0.00979 lower (95% confidence interval 0.0079-0.0117); p = 3 × 10−23.

How common The T allele had a frequency of about 23% in the people studied.

Where it sits Chromosome 1, band 1q25.1 — in an intron of RABGAP1L.

How common each version is

CT
Korean KRGDB
C 92.5% · T 7.5%
Korean Korea4K
C 92.2% · T 7.8%
Japanese ToMMo
C 90.6% · T 9.4%
World gnomAD
C 78.9% · T 21.1%
World 1000 Genomes
C 82.8% · T 17.2%
World TOPMed
C 79.3% · T 20.7%

By ancestry gnomAD

East Asian
C 93.2% · T 6.9%
European (non-Finnish)
C 76.2% · T 23.8%
African / African American
C 85.3% · T 14.7%
South Asian
C 77.5% · T 22.5%
Admixed American (Latino)
C 75.2% · T 24.8%
Middle Eastern
C 82.4% · T 17.6%
Finnish
C 73.6% · T 26.4%
Ashkenazi Jewish
C 68.9% · T 31.1%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C No copy of the version the research linked to Drinks per week. This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Drinks per week. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Drinks per week. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Drinks per week (rs72715245). MyGeneLog™. https://www.mygenelog.com/variants/rs72715245

← See all variants